Cohort (LON:CHRT)

MedPage Today  Jul 12  Comment 
(MedPage Today) -- TBI with loss of consciousness 'not innocuous,' finds analysis of three cohort studies
Benzinga  Jun 22  Comment 
Voyager Therapeutics, Inc. (NASDAQ: VYGR) disclosed interim surgical results from an ongoing Phase 1b study of VY-AADC01 in patients with advanced Parkinson's disease as a poster presentation at the 20th International Congress of Parkinson's...
The Economic Times  Jun 16  Comment 
The Bengaluru-based software services company has a market value of nearly $42 billion—more than the combined estimated worth of India’s startup ‘unicorns’.
Clusterstock  Jun 8  Comment 
The next housing boom will be triggered by millennials. Like older demographic groups, the lumped-together cohort of 20- and 30-somethings is interested in getting married, starting families, buying homes, and living the aspirational suburban...
MedPage Today  May 31  Comment 
(MedPage Today) -- Small cohort with obesity and PCOS saw improvement
TechCrunch  May 26  Comment 
 Acceleprise, a San Francisco-based accelerator for enterprise tech and software-as-a-service startups, held a Demo Day for its third cohort of companies today. The accelerator invests $50,000 into each startup admitted to its program via...  May 20  Comment 
Editors' pick: Originally published May 20. The accepted belief is that Millennials - a generation brought up surrounded by computers - have thrown in their lot with robo-advisers and are shunning traditional financial advisers. As probable as...  May 19  Comment 
SOUTH SAN FRANCISCO (dpa-AFX) - ImmunoGen Inc.'s (IMGN) phase I cohort evaluating Mirvetuximab soravtansine as single-agent therapy for platinum-resistant, folate receptor alpha-positive ovarian cancer has confirmed objective response rate...
MedPage Today  May 12  Comment 
(MedPage Today) -- Cohort study suggests cardioprotection from gout drug



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki